July 28, 2020

Grassley at Hearing on Protecting the Reliability of the U.S. Medical Supply Chain During the COVID-19 Pandemic Part 1

Prepared Opening
Statement by U.S. Senator Chuck Grassley of Iowa

Chairman, Senate Finance
Committee

Tuesday, July 28, 2020

VIDEO

 

Good
morning.

 

I’d
like to welcome everyone to the Finance Committee’s hearing on Protecting the
Reliability of the U.S. Medical Supply Chain during the COVID-19 Pandemic.

 

This
is the first hearing of a series of hearings to discuss the integrity of our
nation’s medical supply chain.

 

Today,
we will hear from the Department of Homeland Security (DHS), and in a few days
we will hear from private sector stakeholders.

 

This
is an extremely important topic to discuss and one that impacts the safety of
all Americans.

 

It’s
Congress’s responsibility to ensure that DHS upholds its responsibility to
protect the public health by properly ensuring that Americans on the frontline
get safe and effective medical supplies.

 

I
think we can all agree. The COVID-19 pandemic has exposed several
vulnerabilities in our nation’s medical supply chain.

 

Some
of these vulnerabilities are new, while others have been around long before the
pandemic and have been further exacerbated by this crisis. Indeed, I’ve been
asking questions long before the pandemic brought these issues to the forefront
of national debate.

 

In
November of last year, I finalized my oversight activities on the proliferation
of counterfeit and other illicit goods sold on e-commerce platforms. 

 

The
Ranking Member and I issued a report on our findings and highlighted the threat
counterfeits pose to our nation’s economic security, and the health and safety
of Americans. 

 

We
also highlighted that many counterfeits originate in China and Hong Kong.

 

At
this point, I think it’s fair to say that China has serious quality control
problems. It was evident then, and even more so now. 

 

Before
the coronavirus pandemic, hospitals and health care workers could avoid
purchasing counterfeits by tapping into tried-and-true supply chains.

 

However,
as the demand for PPE skyrocketed, some of these providers have had to go
outside their normal supply chains to source supplies, and in some cases have
inadvertently purchased fake, faulty and even illicit medical supplies.

 

The
problem of counterfeit and faulty products is something that I’ve looked into
for a very long time, dating back to when I was Chairman of the Judiciary
Committee.

 

As
the virus began its foothold in the United States, I also sent a letter to Vice
President Mike Pence and several other agency heads to express my concern that
PPE shortages were allowing bad actors to take advantage of hospitals and
health care workers desperate for supplies.

 

I’ve
talked to hospitals all over the country, and have heard stories of price
gouging, shady middlemen and PPE that was ordered and then never arrived, or
was unusable.

 

In
my letter, I asked the Administration to take this issue seriously, and to
prosecute bad actors to the fullest extent of the law.

 

Today,
we’ll hear from a representative from U.S. Immigration and Enforcement’s
Homeland Security Investigations on their efforts to do just that.  

 

Before
we hear from today’s witnesses, I want to discuss the substance of today’s
hearing. We will discuss several issues confronting our nation’s supply chain
as our country continues to battle the coronavirus pandemic.

 

First,
I want to go back to the beginning, and expose the root cause of why the United
States – and frankly the world – is experiencing a breakdown of their supply
chains.

 

China
is the largest manufacturer of PPE in the world, with more than 40 percent of
PPE manufactured there.

 

In
the beginning of the pandemic, China did the unthinkable.

 

They
turned off the taps of PPE manufacturing, and heavily restricted their exports
of PPE. The Chinese government also directed its local and state governments to
source more supplies from the international market.

 

As
global demand soon spiked, and China restricted exports, distributors and
suppliers were unable to fulfill orders.

 

As
a result, some hospitals report estimated delays of three to six months for
supplies.

 

Some
pundits say China did what it did it to address a domestic health crisis.
However, it’s important to remember that, in the beginning, China downplayed
the seriousness of the coronavirus threat to the world while it redirected vast
quantities of PPE towards its domestic needs.

 

In
the United States, China’s decision to redirect medical supplies occurred when
states, territories, localities, and tribes began to desperately need these
critical supplies.

 

While
China has since reversed course, and allowed PPE to leave the country, the
United States has continued to struggle to meet demand, with most of our supply
chains heavily dependent on China or Mexico.

 

We
cannot allow our supply chains to rely so heavily on China, and I look forward
to working with my colleagues, on both sides of the aisle, to discuss how we
can diversify our supply chains and increase our domestic manufacturing
capacity.

 

I
want to turn now to how shortages have affected hospitals and health care
workers.

 

Before
the coronavirus pandemic, hospitals and health care providers employed a
“just-in-time-approach” to sourcing supplies from trusted distributors.
However, as the virus gained a foothold in the United States, everyone rushed
to compete for supplies, further exacerbating the shortages. 

 

As
a result, some health care providers resorted to purchasing PPE from unverified
suppliers, and some even turned to the internet to source supplies.

 

By
doing so, these providers sometimes received fake, fraudulent and even illicit
goods not safe for use in treating patients with the coronavirus. In other
cases, providers faced price gouging or hoarding.

 

Fake
N95 masks have become so prolific that 3M recently filed suit against several
purported PPE sellers profiting from COVID-19 at the expense of the sick and
vulnerable.

 

Large
health care systems have told me that the supply chain is doing better now,
with more PPE coming in daily, which gives them the ability to avoid unverified
suppliers altogether.

 

However,
smaller providers continue to face horrific shortages which may cause them to
continue to turn to unverified suppliers, or even the internet, to source
supplies.

 

Even
more concerning is that smaller providers, like safety-net clinics and rural
hospitals, tend to treat low income families, a majority of which are African
Americans and Latinos.

 

This
population has been hit the hardest by the pandemic, and is four to five times
more likely to be hospitalized for contracting the coronavirus.

 

This
is an issue that cannot be sugarcoated, or spun for some political purpose.
It’s a fact.

 

The
black and brown community is suffering.

 

As
members of Congress, and stewards of the public trust, we must do everything in
our power to protect this vulnerable population.

 

This
Committee is considering several proposals to do just that.

 

And
one way we can help this vulnerable population is to do everything in our power
to shore up the integrity of our nation’s supply chain, and make sure that all
hospitals and health care providers get the quality supplies they need to treat
COVID-19 patients.

 

With
that said, I want to now turn to the Department of Homeland Security’s efforts
to protect the integrity of our nation’s supply chain, as we have witnesses
before us today that can speak to this very issue. 

 

DHS
and its components are engaged in an unprecedented, whole-of-government
response to combat the coronavirus pandemic.

 

Our
nation has not faced a pandemic like the coronavirus in more than 100 years.

 

Even
so, we can’t deny that the Federal government’s approach to emergency
preparedness has always been fraught with problems, going back to President
Obama’s Administration and beyond.

 

This
is not some partisan point. It’s a fact.

 

It
also shows that no matter which party is in the White House, we can always do
more to prepare.

 

Today,
we will hear from witnesses that represent DHS’s Office of Procurement, U.S.
Customs and Border Protection, and ICE’s Homeland Security Investigations.

 

Thank
you for being here. I look forward to hearing from all of you.

 

In
closing, I want to say two things. First, I want to thank the DHS officials who
work tirelessly to ensure the integrity of our nation’s supply chain, and for
their efforts to ensure that those in most need get critical, quality medical
supplies. 

 

Your
job is incredibly difficult right now, but it is also incredibly important.

 

Second,
we must come together to address vulnerabilities in our nation’s supply chain.
I hope today we can have a good faith discussion so that we can better
understand what we, as Congress, need to do to protect American’s front line
workers and prepare our country for future national health emergencies. 

Print 
Email 
Share 
Share